CL1 Unveiled — The First Commercial Biocomputer with Neurons
Cortical Labs, a pioneering Australian biotech company, has achieved a major breakthrough with the launch of CL1, the world’s first commercial biocomputer. Combining human neurons with silicon components, this device promises to redefine computing and artificial intelligence.
CL1 is built on the concept of Synthetic Biological Intelligence (SBI), where lab-grown neurons serve as the core processing unit. These cells self-organize into dynamic networks, capable of processing information exponentially faster than traditional AI algorithms. Unlike conventional systems that require vast computational resources for training, biological networks adapt autonomously while consuming minimal energy.
CL1's predecessor, the DishBrain system (2022), made headlines when 800,000 human and mouse neurons successfully learned to play Pong. The startup’s next goal is to develop a "Minimally Viable Brain" (MVB)—a simplified neural network capable of handling complex tasks.
The first commercial CL1 units will be available to research labs in the second half of 2025, with prices starting at $35,000. The technology has already attracted interest from pharmaceutical giants and IT corporations. Experts believe SBI could complement AI, offering solutions where rapid learning and energy efficiency are crucial.
